Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
arXiv:1308.6028 · doi:10.1371/journal.pcbi.1002316
Abstract
Tumors are defined by their intense proliferation, but sometimes cancer cells turn senescent and stop replicating. In the stochastic cancer model in which all cells are tumorigenic, senescence is seen as the result of random mutations, suggesting that it could represent a barrier to tumor growth. In the hierarchical cancer model a subset of the cells, the cancer stem cells, divide indefinitely while other cells eventually turn senescent. Here we formulate cancer growth in mathematical terms and obtain predictions for the evolution of senescence. We perform experiments in human melanoma cells which are compatible with the hierarchical model and show that senescence is a reversible process controlled by survivin. We conclude that enhancing senescence is unlikely to provide a useful therapeutic strategy to fight cancer, unless the cancer stem cells are specifically targeted
References in corpus (1)
Cited by in corpus (7)
- Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential mechanism
- Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
- Overshoot during phenotypic switching of cancer cell populations
- Modeling tumorspheres reveals cancer stem cell niche building and plasticity
- Growth and form of melanoma cell colonies
- Radial percolation reveals that Cancer Stem Cells are trapped in the core of tumorspheres
- Accounting for Randomness in Measurement and Sampling in Study of Cancer Cell Population Dynamics